Synthesis, characterization, and in silico studies of 1, 8-naphthyridine derivatives as potential anti-Parkinson's agents. Issue 3 (11th February 2023)

• Record Type: Journal Article
• Authors: Ojha, Madhwi; Kumar, Avinash; Prasun, Chakrawarti; Nair, Maya S.; Chaturvedi, Saurabh; Paliwal, Sarvesh Kumar; Nain, Sumitra
• Is Part Of: Journal of biomolecular structure & dynamics. Volume 41:Issue 3(2023)
• Page Start: 805
• Page End: 820
• Publication Date: 2023-02-11
• Subjects: 1, 8-Naphthyridine -- Parkinson's disease -- dopamine -- neurodegenerative disease; Biomolecules -- Periodicals; Molecular structure -- Periodicals; Molecular Biology -- Periodicals; Biomechanics -- Periodicals; 572
• DOI: 10.1080/07391102.2021.2013320
• Languages: English
• ISSNs: 0739-1102

Abstract

Abstract: 1, 8- Naphthyridine scaffold is a nitrogen-containing heterocyclic compound known for its versatile biological activities. The structure-activity relationship (SAR) has shown that modification at the 3rd position of the nucleus with various secondary amines enhances the binding efficiency and potency towards the Adenosine receptor (A2A type). In this paper, we have reported some newly synthesized derivatives of 1, 8- Naphthyridine, and the prepared compounds were assessed for their potential to constrain A2A receptors through molecular docking. Based on the SAR studies, modifications were done at the 3rd position of the nucleus by incorporating secondary amines. The synthesized compounds were characterized by FT-IR, 1 H and 13 C NMR. All the synthesized compounds 10a-f and 13a-e showed good binding efficiency towards the A2A receptors and might act as an A2A receptor antagonist, as predicted by in-silico studies. 1-Ethyl-7-methyl-3-(pyrrolidine-1-carbonyl)-1, 8-naphthyridine-4(1H)-one (10c) in first series showed the highest docking score of −8.407 and binding energy (MMGBSA dG bind) of –56.60 kcal/mol and N-(4-2-diethylaminoethoxyphenyl)-1-ethyl-7-methyl-4-oxo-1, 4, 4a, 8a- tetrahydro-1, 8-naphthyridine-3-carboxamide (13b) showed the highest docking score of –8.562 and free binding energy (MMGBSA dG bind) score of –64.13 kcal/mol which was comparable to the bound ligand. MD simulations study also suggested that compounds 10c and 13b would form stable complex human A2A receptor. These findings need to be validated by further in vitro assays. Communicated by Ramaswamy H. Sarma